{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T14:10:20Z","timestamp":1773324620739,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.schres.2026.01.023","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T08:30:41Z","timestamp":1770193841000},"page":"57-64","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Predicting the prognosis of primary and substance-associated psychoses using urine drug screens: A 5-year retrospective longitudinal study using medical records"],"prefix":"10.1016","volume":"290","author":[{"given":"Erich J.","family":"Aschenbrenner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew C.","family":"Voluse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2026.01.023_bb0005","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1007\/s00213-017-4551-7","article-title":"A comparison of psychotic symptoms in subjects with methamphetamine versus cocaine dependence","volume":"234","author":"Alexander","year":"2017","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.schres.2026.01.023_bb0010","doi-asserted-by":"crossref","first-page":"95","DOI":"10.20882\/adicciones.1291","article-title":"Differences between substance-induced psychotic disorders and non-substance-induced psychotic disorders and diagnostic stability","volume":"35","author":"Cambra Almerge","year":"2023","journal-title":"Adicciones"},{"key":"10.1016\/j.schres.2026.01.023_bb0015","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/00223890802634175","article-title":"The analysis of count data: a gentle introduction to Poisson regression and its alternatives","volume":"91","author":"Coxe","year":"2009","journal-title":"J. Pers. Assess."},{"key":"10.1016\/j.schres.2026.01.023_bb0020","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0376-8716(03)00064-4","article-title":"Testing hypotheses about the relationship between cannabis use and psychosis","volume":"71","author":"Degenhardt","year":"2003","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.schres.2026.01.023_bb0025","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1007\/s11469-024-01279-z","article-title":"Unraveling the complexities of substance-induced psychosis and its transition to independent psychosis: a ten-year retrospective cohort study","volume":"23","author":"Ghosh","year":"2025","journal-title":"Int. J. Ment. Health Addict."},{"key":"10.1016\/j.schres.2026.01.023_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2021.114361","article-title":"Substance-induced psychosis and cognitive functioning: a systematic review","volume":"308","author":"Gicas","year":"2022","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.schres.2026.01.023_bb0035","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.drugalcdep.2018.07.011","article-title":"Prevalence of comorbid substance use in schizophrenia spectrum disorders in community and clinical settings, 1990\u20132017: systematic review and meta-analysis","volume":"191","author":"Hunt","year":"2018","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.schres.2026.01.023_bb0040","first-page":"272","article-title":"Diagnostic stability in substance-induced psychosis","volume":"15","author":"Inchausti","year":"2022","journal-title":"Rev. De Psiquiatr. Salud Ment. (English Ed.)"},{"key":"10.1016\/j.schres.2026.01.023_bb0045","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.22m14458","article-title":"The economic burden of schizophrenia in the United States","volume":"83","author":"Kadakia","year":"2022","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2026.01.023_bb0050","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1176\/appi.ajp.2019.18101217","article-title":"Prediction of onset of substance-induced psychotic disorder and its progression to schizophrenia in a Swedish national sample","volume":"176","author":"Kendler","year":"2019","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2026.01.023_bb0055","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1177\/0004867414525838","article-title":"Systematic meta-analysis of outcomes associated with psychosis and co-morbid substance use","volume":"48","author":"Large","year":"2014","journal-title":"Aust. N.Z. J. Psychiatry"},{"key":"10.1016\/j.schres.2026.01.023_bb0060","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/10550490701861201","article-title":"Presence and persistence of psychotic symptoms in cocaine-versus methamphetamine-dependent participants","volume":"17","author":"Mahoney","year":"2008","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.schres.2026.01.023_bb0065","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.psychres.2017.02.028","article-title":"Differences in the symptom profile of methamphetamine-related psychosis and primary psychotic disorders","volume":"251","author":"McKetin","year":"2017","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.schres.2026.01.023_bb0070","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1176\/appi.ajp.20230329","article-title":"Risk of incident psychosis and mania with prescription amphetamines","volume":"181","author":"Moran","year":"2024","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2026.01.023_bb0075","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.schres.2018.11.007","article-title":"Characteristics and outcomes of young people with substance induced psychotic disorder","volume":"206","author":"O\u2019Connell","year":"2019","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2026.01.023_bb0080","doi-asserted-by":"crossref","DOI":"10.1007\/BF02854914","article-title":"Mechanisms of methamphetamine-induced dopaminergic neurotoxicity","volume":"8","author":"Riddle","year":"2006","journal-title":"AAPS J."},{"key":"10.1016\/j.schres.2026.01.023_bb0085","doi-asserted-by":"crossref","first-page":"5246","DOI":"10.1017\/S003329172200229X","article-title":"Annual incidence of substance-induced psychoses in Scandinavia from 2000 to 2016","volume":"53","author":"Rognli","year":"2023","journal-title":"Psychol. Med."},{"key":"10.1016\/j.schres.2026.01.023_bb0090","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1176\/ps.2006.57.10.1468","article-title":"Diagnosing psychotic disorders in the emergency department in the context of substance use","volume":"57","author":"Schanzer","year":"2006","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.schres.2026.01.023_bb1000","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ajp.2017.10.003","article-title":"Cannnabis induced psychosis and subsequent psychiatric disorders","volume":"30","author":"Shah","year":"2017","journal-title":"Asian J. Psychiatry"},{"key":"10.1016\/j.schres.2026.01.023_bb0095","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s12272-017-0897-y","article-title":"Current understanding of methamphetamine-associated dopaminergic neurodegeneration and psychotoxic behaviors","volume":"40","author":"Shin","year":"2017","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.schres.2026.01.023_bb0100","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.comppsych.2008.07.009","article-title":"Prevalence of psychotic symptoms in substance users: a comparison across substances","volume":"50","author":"Smith","year":"2009","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.schres.2026.01.023_bb0105","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1176\/appi.ajp.2017.17020223","article-title":"Rates and predictors of conversion to schizophrenia or bipolar disorder following substance-induced psychosis","volume":"175","author":"Starzer","year":"2018","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2026.01.023_bb0110","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1007\/s00127-013-0651-9","article-title":"Annual incidence rate of schizophrenia and schizophrenia spectrum disorders in a longitudinal population-based cohort study","volume":"48","author":"Sutterland","year":"2013","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"key":"10.1016\/j.schres.2026.01.023_bb0115","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/acps.12623","article-title":"Short-term outcome of substance-induced psychotic disorder in a large UK first episode psychosis cohort","volume":"134","author":"Thompson","year":"2016","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2026.01.023_bb0120","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1080\/10826084.2018.1521430","article-title":"A systematic review of the symptom profile and course of methamphetamine-associated psychosis","volume":"54","author":"Voce","year":"2019","journal-title":"Subst. Use Misuse"},{"key":"10.1016\/j.schres.2026.01.023_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2022.103685","article-title":"Impact of cannabis legalization on healthcare utilization for psychosis and schizophrenia in Colorado","volume":"104","author":"Wang","year":"2022","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.schres.2026.01.023_bb0130","doi-asserted-by":"crossref","DOI":"10.1186\/1471-244X-13-319","article-title":"Treated incidence and baseline characteristics of substance induced psychosis in a Norwegian catchment area","volume":"13","author":"Weibell","year":"2013","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.schres.2026.01.023_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109270","article-title":"Occurrence and severity of cocaine-induced hallucinations: two distinct phenotypes with shared clinical factors but specific genetic risk factors","volume":"232","author":"Zerdazi","year":"2022","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.schres.2026.01.023_bb0140","article-title":"Psychosis among individuals with methamphetamine use disorder is associated with elevated rates of hospitalizations and emergency department visits across an academic health care system","volume":"151","author":"Zito","year":"2023","journal-title":"J. Subst. Use Addict. Treat."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996426000307?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996426000307?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T23:37:27Z","timestamp":1773272247000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996426000307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":29,"alternative-id":["S0920996426000307"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2026.01.023","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predicting the prognosis of primary and substance-associated psychoses using urine drug screens: A 5-year retrospective longitudinal study using medical records","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2026.01.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}